GTPL Hathway Ltd: Intrinsic Value & Share Price Analysis

Last Updated: December 12, 2025, 5:34 pm

All Competitor Stocks of GTPL Hathway Ltd

Last Updated: August 1, 2025, 8:35 pm

Below is a detailed analysis of the quarterly data for GTPL Hathway Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 903.70 Cr.. The value appears strong and on an upward trend. It has increased from 890.99 Cr. (Mar 2025) to 903.70 Cr., marking an increase of 12.71 Cr..
• For Expenses, as of Jun 2025, the value is 796.84 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 785.65 Cr. (Mar 2025) to 796.84 Cr., marking an increase of 11.19 Cr..
• For Operating Profit, as of Jun 2025, the value is 106.86 Cr.. The value appears strong and on an upward trend. It has increased from 105.34 Cr. (Mar 2025) to 106.86 Cr., marking an increase of 1.52 Cr..
• For OPM %, as of Jun 2025, the value is 11.82%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 11.82%.
• For Other Income, as of Jun 2025, the value is 5.42 Cr.. The value appears to be declining and may need further review. It has decreased from 7.83 Cr. (Mar 2025) to 5.42 Cr., marking a decrease of 2.41 Cr..
• For Interest, as of Jun 2025, the value is 8.64 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8.36 Cr. (Mar 2025) to 8.64 Cr., marking an increase of 0.28 Cr..
• For Depreciation, as of Jun 2025, the value is 91.41 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 93.66 Cr. (Mar 2025) to 91.41 Cr., marking a decrease of 2.25 Cr..
• For Profit before tax, as of Jun 2025, the value is 12.23 Cr.. The value appears strong and on an upward trend. It has increased from 11.15 Cr. (Mar 2025) to 12.23 Cr., marking an increase of 1.08 Cr..
• For Tax %, as of Jun 2025, the value is 40.07%. The value appears to be increasing, which may not be favorable. It has increased from 2.78% (Mar 2025) to 40.07%, marking an increase of 37.29%.
• For Net Profit, as of Jun 2025, the value is 7.32 Cr.. The value appears to be declining and may need further review. It has decreased from 10.83 Cr. (Mar 2025) to 7.32 Cr., marking a decrease of 3.51 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.94. The value appears to be declining and may need further review. It has decreased from 0.95 (Mar 2025) to 0.94, marking a decrease of 0.01.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:15 am

Growth

Last Updated: September 5, 2025, 5:30 am

Balance Sheet

Last Updated: December 4, 2025, 1:19 am

Below is a detailed analysis of the balance sheet data for GTPL Hathway Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 112.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 112.00 Cr..
• For Reserves, as of Sep 2025, the value is 1,038.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,051.00 Cr. (Mar 2025) to 1,038.00 Cr., marking a decrease of 13.00 Cr..
• For Borrowings, as of Sep 2025, the value is 375.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 313.00 Cr. (Mar 2025) to 375.00 Cr., marking an increase of 62.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 2,272.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,759.00 Cr. (Mar 2025) to 2,272.00 Cr., marking an increase of 513.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 3,798.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,236.00 Cr. (Mar 2025) to 3,798.00 Cr., marking an increase of 562.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 2,073.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,058.00 Cr. (Mar 2025) to 2,073.00 Cr., marking an increase of 15.00 Cr..
• For CWIP, as of Sep 2025, the value is 103.00 Cr.. The value appears to be declining and may need further review. It has decreased from 118.00 Cr. (Mar 2025) to 103.00 Cr., marking a decrease of 15.00 Cr..
• For Investments, as of Sep 2025, the value is 11.00 Cr.. The value appears to be declining and may need further review. It has decreased from 12.00 Cr. (Mar 2025) to 11.00 Cr., marking a decrease of 1.00 Cr..
• For Other Assets, as of Sep 2025, the value is 1,610.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,048.00 Cr. (Mar 2025) to 1,610.00 Cr., marking an increase of 562.00 Cr..
• For Total Assets, as of Sep 2025, the value is 3,798.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,236.00 Cr. (Mar 2025) to 3,798.00 Cr., marking an increase of 562.00 Cr..

Notably, the Reserves (1,038.00 Cr.) exceed the Borrowings (375.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for GTPL Hathway Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 4.26. This value is below the healthy minimum of 5. It has decreased from 9.51 (Mar 24) to 4.26, marking a decrease of 5.25.
• For Diluted EPS (Rs.), as of Mar 25, the value is 4.26. This value is below the healthy minimum of 5. It has decreased from 9.51 (Mar 24) to 4.26, marking a decrease of 5.25.
• For Cash EPS (Rs.), as of Mar 25, the value is 37.15. This value is within the healthy range. It has decreased from 39.94 (Mar 24) to 37.15, marking a decrease of 2.79.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 103.49. It has increased from 103.13 (Mar 24) to 103.49, marking an increase of 0.36.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 103.49. It has increased from 103.13 (Mar 24) to 103.49, marking an increase of 0.36.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 309.19. It has increased from 285.65 (Mar 24) to 309.19, marking an increase of 23.54.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 41.13. This value is within the healthy range. It has decreased from 45.45 (Mar 24) to 41.13, marking a decrease of 4.32.
• For PBIT / Share (Rs.), as of Mar 25, the value is 8.34. This value is within the healthy range. It has decreased from 15.47 (Mar 24) to 8.34, marking a decrease of 7.13.
• For PBT / Share (Rs.), as of Mar 25, the value is 5.69. This value is within the healthy range. It has decreased from 13.43 (Mar 24) to 5.69, marking a decrease of 7.74.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 4.36. This value is within the healthy range. It has decreased from 9.96 (Mar 24) to 4.36, marking a decrease of 5.60.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 4.26. This value is within the healthy range. It has decreased from 9.51 (Mar 24) to 4.26, marking a decrease of 5.25.
• For PBDIT Margin (%), as of Mar 25, the value is 13.30. This value is within the healthy range. It has decreased from 15.91 (Mar 24) to 13.30, marking a decrease of 2.61.
• For PBIT Margin (%), as of Mar 25, the value is 2.69. This value is below the healthy minimum of 10. It has decreased from 5.41 (Mar 24) to 2.69, marking a decrease of 2.72.
• For PBT Margin (%), as of Mar 25, the value is 1.83. This value is below the healthy minimum of 10. It has decreased from 4.70 (Mar 24) to 1.83, marking a decrease of 2.87.
• For Net Profit Margin (%), as of Mar 25, the value is 1.41. This value is below the healthy minimum of 5. It has decreased from 3.48 (Mar 24) to 1.41, marking a decrease of 2.07.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.37. This value is below the healthy minimum of 8. It has decreased from 3.33 (Mar 24) to 1.37, marking a decrease of 1.96.
• For Return on Networth / Equity (%), as of Mar 25, the value is 4.11. This value is below the healthy minimum of 15. It has decreased from 9.22 (Mar 24) to 4.11, marking a decrease of 5.11.
• For Return on Capital Employeed (%), as of Mar 25, the value is 6.16. This value is below the healthy minimum of 10. It has decreased from 11.66 (Mar 24) to 6.16, marking a decrease of 5.50.
• For Return On Assets (%), as of Mar 25, the value is 1.46. This value is below the healthy minimum of 5. It has decreased from 3.50 (Mar 24) to 1.46, marking a decrease of 2.04.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 0.2. It has decreased from 0.05 (Mar 24) to 0.04, marking a decrease of 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.19. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.19.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.10. It has decreased from 1.11 (Mar 24) to 1.10, marking a decrease of 0.01.
• For Current Ratio (X), as of Mar 25, the value is 0.51. This value is below the healthy minimum of 1.5. It has increased from 0.46 (Mar 24) to 0.51, marking an increase of 0.05.
• For Quick Ratio (X), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1. It has increased from 0.44 (Mar 24) to 0.50, marking an increase of 0.06.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 42.04 (Mar 24) to 0.00, marking a decrease of 42.04.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 10.12 (Mar 24) to 0.00, marking a decrease of 10.12.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 57.96 (Mar 24) to 0.00, marking a decrease of 57.96.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 89.88 (Mar 24) to 0.00, marking a decrease of 89.88.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 15.60. This value is within the healthy range. It has decreased from 22.32 (Mar 24) to 15.60, marking a decrease of 6.72.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.66. This value is below the healthy minimum of 3. It has decreased from 5.89 (Mar 24) to 2.66, marking a decrease of 3.23.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,458.07. It has decreased from 2,083.42 (Mar 24) to 1,458.07, marking a decrease of 625.35.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.41. This value is below the healthy minimum of 1. It has decreased from 0.64 (Mar 24) to 0.41, marking a decrease of 0.23.
• For EV / EBITDA (X), as of Mar 25, the value is 3.15. This value is below the healthy minimum of 5. It has decreased from 4.08 (Mar 24) to 3.15, marking a decrease of 0.93.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.34. This value is below the healthy minimum of 1. It has decreased from 0.58 (Mar 24) to 0.34, marking a decrease of 0.24.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 57.95 (Mar 24) to 0.00, marking a decrease of 57.95.
• For Price / BV (X), as of Mar 25, the value is 1.05. This value is within the healthy range. It has decreased from 1.62 (Mar 24) to 1.05, marking a decrease of 0.57.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.34. This value is below the healthy minimum of 1. It has decreased from 0.58 (Mar 24) to 0.34, marking a decrease of 0.24.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.05 (Mar 24) to 0.03, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness